Northbound funds | Northbound trading volume reached a net buying of 5.345 billion yuan, with Europe and America adding sanctions on Russian oil. Northbound trading also increased its position in CNOOC (00883) by nearly 1 billion Hong Kong dollars.

In the Hong Kong stock market on October 23, Beishui had a net buying of 5.345 billion Hong Kong dollars, with a net buying of 4.77 billion Hong Kong dollars through the Shanghai-Hong Kong Stock Connect and a net buying of 575 million Hong Kong dollars through the Shenzhen-Hong Kong Stock Connect. The stocks with the most net buying by Beishui were CNOOC (00883), POP MART (09992), and MEITUAN-W (03690). The stocks with the most net selling by Beishui were HUA HONG SEMI (01347), INNOVENT BIO (01801), and XIAOMI-W (01810). Active trading stocks through Shanghai-Hong Kong Stock Connect. Active trading stocks through Shenzhen-Hong Kong Stock Connect. CNOOC (00883) had a net buying of 979 million Hong Kong dollars. On the news front, the U.S. Treasury Department issued a statement on the 22nd local time declaring sanctions on two of Russia's core oil companies - Rosneft and Lukoil - citing Russia's "lack of political will to end the conflict in Ukraine." The EU rotating presidency Denmark announced that all 27 EU countries have approved the 19th round of sanctions against Russia, further squeezing Russia's energy export channels. International oil prices continued to rise, with WTI crude oil and Brent crude oil both rising by more than 5%. POP MART (09992) had a net buying of 793 million Hong Kong dollars. According to a research report by Morgan Stanley, POP MART's third-quarter sales grew by 245% to 250%, far exceeding the bank's forecast of 180%, further accelerating from the second quarter's growth of about 235%. By region, sales in Greater China increased by 185% to 190% during the period, while overseas sales increased by 365% to 370%, with Asia-Pacific rising by 170% to 175%, the Americas by 1265% to 1270%, and Europe by 735% to 740%. Growth in all markets exceeded expectations. MEITUAN-W (03690) had a net buying of 524 million Hong Kong dollars. On October 20, Meituan announced that the head of hardware and software services, Xiao Fei, and the head of the Keeta business, Qiu Guangyu, have joined Meituan's highest decision-making body S-team, seen as an important signal of Meituan's further emphasis on its overseas business strategy. In addition, starting from October 30, Keeta, a brand under Meituan, will officially launch operations in the Brazilian market, with the initial pilot cities being Santos and So Vicente in the coastal state of So Paulo. Chip stocks showed divergence, with Semiconductor Manufacturing International Corporation (00981) having a net buying of 425 million Hong Kong dollars, while HUA HONG SEMI (01347) experienced a net selling of 1.014 billion Hong Kong dollars. According to a report by Morgan Stanley, the booming development of AI applications and policy support for domestic AI GPU are expected to boost demand for advanced wafer foundry in the next two years. The bank raised its rating and target price for Semiconductor Manufacturing International Corporation, assuming that the gross margin will increase with the improvement of yield rates, and expecting higher revenue structure from AI high-performance computing demand. The bank downgraded HUA HONG SEMI, expressing concerns over the sustainability of mature node businesses. GIANT BIOGENE (02367) had a net buying of 359 million Hong Kong dollars. GIANT BIOGENE announced that its wholly-owned subsidiary GIANT BIOGENE in Shaanxi received the "Medical Device Registration Certificate of the People's Republic of China" issued by the National Medical Products Administration for the recombinant type I 1 subtype collagen freeze-dried fiber product. This product, with recombinant collagen as the main component, is used for facial dermal tissue filling to correct dynamic wrinkles in the forehead, including glabellar lines, forehead wrinkles, and crow's feet. Additionally, Tencent (00700) and BABA-W (09988) had net buying of 265 million and 153 million Hong Kong dollars respectively. Meanwhile, INNOVENT BIO (01801) and XIAOMI-W (01810) experienced net selling of 140 million and 57.32 million Hong Kong dollars respectively.